As of Dec. 19, the Southeastern, Southern, and Mid-Atlantic regions of the U.S. are experiencing an increase of emergency ...

Infants given the monoclonal antibody nirsevimab (Beyfortus) to provide passive immunity against respiratory syncytial virus ...

Our top RSV content of 2025 included how nirsevimab and clesrovimab changed RSV prevention among younger patients, as well as ...

We continue our look at contagious illnesses circulating right now with a focus on RSV, which stands for respiratory syncytial virus. “It most commonly causes disease in young children under ...

The U.S. reportedly plans to overhaul the country’s childhood vaccine schedule. The move could set public health back decades ...

A CDC-funded trial withholding timely Hepatitis B vaccination from newborns in the tiny African country echoes historical ...

Vaccine safety monitoring in the US is a multilayered process that combines passive and active functions, as well as expert ...

A strict new vaccine approval process in the U.S. could dramatically slow things down for biopharma and the public, experts ...

Learn how to identify RSV symptoms in adults, how to know if an RSV infection has become serious, how to avoid RSV, and ...

The health sector is working to navigate what could be the most significant changes to the U.S. vaccine program in decades.

The Trump administration is planning to announce an overhaul to the childhood immunization schedule early next year, ...

The following information was released by the Henry J. Kaiser Family Foundation:. Specifically, under the auspices of Secretary Kennedy, who has long questioned the safety and efficacy of vaccines and ...